We also demonstrated that expression of BAFF-R was reduced on most B cell subsets of CIS/MS patients and observed phenotypical and functional associations with reduced B cell BAFF-R in CIS/MS. The gene discussed is TNFRSF13C; the disease is myeloid sarcoma.